SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-021202
Filing Date
2023-03-27
Accepted
2023-03-27 16:05:22
Documents
1
Period of Report
2023-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4022
  Complete submission text file 0001209191-23-021202.txt   5469
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 GREAT VALLEY PARKWAY, SUITE 160 MALVERN PA 19355
Business Address
Subramanian Sanjay (Reporting) CIK: 0001790246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 23764551